Literature DB >> 29498204

Association of impaired endothelial glycocalyx with arterial stiffness, coronary microcirculatory dysfunction, and abnormal myocardial deformation in untreated hypertensives.

Ignatios Ikonomidis1, Astrinos Voumvourakis1, George Makavos1, Helen Triantafyllidi1, George Pavlidis1, Konstantinos Katogiannis1, Dimitris Benas1, Dimitris Vlastos1, Paraskevi Trivilou1, Maria Varoudi1, John Parissis1, Efstathios Iliodromitis1, John Lekakis1.   

Abstract

We investigated the association of endothelial glycocalyx damage with arterial stiffness, impairment of coronary microcirculatory function, and LV myocardial deformation in 320 untreated hypertensives and 160 controls. We measured perfused boundary region (PBR) of the sublingual microvessels, a marker inversely related with glycocalyx thickness, coronary flow reserve (CFR), and Global Longitudinal strain (GLS) by echocardiography, pulse wave velocity (PWV), and central systolic blood pressure (cSBP). Hypertensives had higher PBR, PWV cSBP, and lower CFR and GLS than controls (P < .05). In hypertensives, increased PBR was associated with increased cSBP, PWV, and decreased CFR and GLS after adjustment for age, sex, BMI, smoking LV mass, heart rate, hyperlipidemia, and office SBP (P < .05). PBR had an additive value to PWV, CFR, and office SBP for the prediction of abnormal GLS (x2  = 2.4-3.8, P for change = .03). Endothelial glycocalyx is impaired in untreated hypertensives and is related to arterial stiffness, coronary, and myocardial dysfunction. ©2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  arterial stiffness; endothelial glycocalyx; longitudinal strain; pulse wave velocity

Mesh:

Year:  2018        PMID: 29498204      PMCID: PMC8030968          DOI: 10.1111/jch.13236

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  40 in total

1.  Conduit arterial stiffness is associated with impaired left ventricular subendocardial function.

Authors:  D Vinereanu; E Nicolaides; L Boden; N Payne; C J H Jones; A G Fraser
Journal:  Heart       Date:  2003-04       Impact factor: 5.994

Review 2.  Endothelial glycocalyx and coronary vascular permeability: the fringe benefit.

Authors:  Bernhard F Becker; Daniel Chappell; Matthias Jacob
Journal:  Basic Res Cardiol       Date:  2010-09-22       Impact factor: 17.165

Review 3.  Hypothesis: arterial glycocalyx dysfunction is the first step in the atherothrombotic process.

Authors:  M I M Noble; A J Drake-Holland; H Vink
Journal:  QJM       Date:  2008-03-04

4.  The evaluation of pulse wave velocity using Arteriograph and Complior apparatus across multiple cohorts of cardiovascular-related diseases.

Authors:  Ignatios Ikonomidis; Konstantina Ntai; Nikolaos P E Kadoglou; Ioannis Papadakis; Michael Kornelakis; Vlassis Tritakis; Maria Varoudi; Theodora Papadima; Helen Triantafyllidi; John Parissis; Ioannis Paraskevaidis; John Lekakis
Journal:  Int J Cardiol       Date:  2013-07-27       Impact factor: 4.164

5.  Vascular glycocalyx sodium store – determinant of salt sensitivity?

Authors:  Hans Oberleithner; Marianne Wilhelmi
Journal:  Blood Purif       Date:  2015-01-20       Impact factor: 2.614

6.  Cell-free layer and wall shear stress variation in microvessels.

Authors:  Xuewen Yin; Junfeng Zhang
Journal:  Biorheology       Date:  2012       Impact factor: 1.875

7.  Incremental value of pulse wave velocity in the determination of coronary microcirculatory dysfunction in never-treated patients with essential hypertension.

Authors:  Ignatios Ikonomidis; John Lekakis; Costas Papadopoulos; Helen Triantafyllidi; Ioannis Paraskevaidis; Georgia Georgoula; Stavros Tzortzis; Ioanna Revela; Dimitrios Th Kremastinos
Journal:  Am J Hypertens       Date:  2008-05-22       Impact factor: 2.689

8.  Inflammation- and ischemia-induced shedding of venular glycocalyx.

Authors:  A W Mulivor; H H Lipowsky
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-01-02       Impact factor: 4.733

9.  Salt overload damages the glycocalyx sodium barrier of vascular endothelium.

Authors:  Hans Oberleithner; Wladimir Peters; Kristina Kusche-Vihrog; Stefanie Korte; Hermann Schillers; Katrin Kliche; Kilian Oberleithner
Journal:  Pflugers Arch       Date:  2011-07-28       Impact factor: 3.657

10.  Endothelial surface glycocalyx can regulate flow-induced nitric oxide production in microvessels in vivo.

Authors:  Wanyi Yen; Bin Cai; Jinlin Yang; Lin Zhang; Min Zeng; John M Tarbell; Bingmei M Fu
Journal:  PLoS One       Date:  2015-01-09       Impact factor: 3.240

View more
  17 in total

Review 1.  The Endothelial Glycocalyx: A Possible Therapeutic Target in Cardiovascular Disorders.

Authors:  Anastasia Milusev; Robert Rieben; Nicoletta Sorvillo
Journal:  Front Cardiovasc Med       Date:  2022-05-13

2.  Association of impaired endothelial glycocalyx with arterial stiffness, coronary microcirculatory dysfunction, and abnormal myocardial deformation in untreated hypertensives.

Authors:  Ignatios Ikonomidis; Astrinos Voumvourakis; George Makavos; Helen Triantafyllidi; George Pavlidis; Konstantinos Katogiannis; Dimitris Benas; Dimitris Vlastos; Paraskevi Trivilou; Maria Varoudi; John Parissis; Efstathios Iliodromitis; John Lekakis
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-03-02       Impact factor: 3.738

3.  HDL cholesterol levels and endothelial glycocalyx integrity in treated hypertensive patients.

Authors:  Helen Triantafyllidi; Dimitris Benas; Stefanos Vlachos; Dimitris Vlastos; George Pavlidis; Antonios Schoinas; Mary Varoudi; Dionysia Birmpa; Paraskevi Moutsatsou; John Lekakis; Ignatios Ikonomidis
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-10-13       Impact factor: 3.738

4.  Accessing and Assessing the Cell-Surface Glycocalyx Using DNA Origami.

Authors:  Piyumi Wijesekara; Ying Liu; Weitao Wang; Elizabeth K Johnston; Mara L G Sullivan; Rebecca E Taylor; Xi Ren
Journal:  Nano Lett       Date:  2021-05-24       Impact factor: 11.189

5.  Sublingual endothelial glycocalyx and atherosclerosis. A cross-sectional study.

Authors:  Luca Valerio; Ron J Peters; Aeilko H Zwinderman; Sara-Joan Pinto-Sietsma
Journal:  PLoS One       Date:  2019-03-27       Impact factor: 3.240

Review 6.  Microvascular and lymphatic dysfunction in HFpEF and its associated comorbidities.

Authors:  Ilona Cuijpers; Steven J Simmonds; Marc van Bilsen; Elżbieta Czarnowska; Arantxa González Miqueo; Stephane Heymans; Annika R Kuhn; Paul Mulder; Anna Ratajska; Elizabeth A V Jones; Ebba Brakenhielm
Journal:  Basic Res Cardiol       Date:  2020-05-25       Impact factor: 17.165

7.  Sex-related associations of high-density lipoprotein cholesterol with aortic stiffness and endothelial glycocalyx integrity in treated hypertensive patients.

Authors:  Helen Triantafyllidi; Dimitris Benas; Antonios Schoinas; Mary Varoudi; John Thymis; Gavriela Kostelli; Dionysia Birmpa; Ignatios Ikonomidis
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-13       Impact factor: 3.738

8.  Effects of Anti-Inflammatory Treatment and Surgical Intervention on Endothelial Glycocalyx, Peripheral and Coronary Microcirculatory Function and Myocardial Deformation in Inflammatory Bowel Disease Patients: A Two-Arms Two-Stage Clinical Trial.

Authors:  Charilaos Triantafyllou; Maria Nikolaou; Ignatios Ikonomidis; Giorgos Bamias; Dimitrios Kouretas; Ioanna Andreadou; Maria Tsoumani; John Thymis; Ioannis Papaconstantinou
Journal:  Diagnostics (Basel)       Date:  2021-05-30

Review 9.  Shared Features of Endothelial Dysfunction between Sepsis and Its Preceding Risk Factors (Aging and Chronic Disease).

Authors:  Jesus F Bermejo-Martin; Marta Martín-Fernandez; Cristina López-Mestanza; Patricia Duque; Raquel Almansa
Journal:  J Clin Med       Date:  2018-10-30       Impact factor: 4.241

10.  A Low Tacrolimus Concentration/Dose Ratio Increases the Risk for the Development of Acute Calcineurin Inhibitor-Induced Nephrotoxicity.

Authors:  Gerold Thölking; Katharina Schütte-Nütgen; Julia Schmitz; Alexandros Rovas; Maximilian Dahmen; Joachim Bautz; Ulrich Jehn; Hermann Pavenstädt; Barbara Heitplatz; Veerle Van Marck; Barbara Suwelack; Stefan Reuter
Journal:  J Clin Med       Date:  2019-10-02       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.